Evidence map›Paper›PMID 24503863›Full record

ArticleScientific reports2014

Rapid interferometric imaging of printed drug laden multilayer structures.

Niklas Sandler, Ivan Kassamakov, Henrik Ehlers, Natalja Genina, Tuomo Ylitalo, Edward Haeggstrom

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Bioactive Potential of 3D-Printed Oleo-Gum-Resin Disks:Bioinorganic chemistry and applications · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Niklas SandlerPharmaceutical Sciences Laboratory, Department of Biosciences, Abo Akademi University, Tykistökatu 6A, FI-20520 Turku, Finland.
Ivan KassamakovElectronics Research Laboratory, Department of Physics, Division of Materials Physics, University of Helsinki, P.O. Box 64, FI-00014 Helsinki, Finland.
Henrik EhlersPharmaceutical Sciences Laboratory, Department of Biosciences, Abo Akademi University, Tykistökatu 6A, FI-20520 Turku, Finland.
Natalja GeninaPharmaceutical Sciences Laboratory, Department of Biosciences, Abo Akademi University, Tykistökatu 6A, FI-20520 Turku, Finland.
Tuomo YlitaloElectronics Research Laboratory, Department of Physics, Division of Materials Physics, University of Helsinki, P.O. Box 64, FI-00014 Helsinki, Finland.
Edward HaeggstromElectronics Research Laboratory, Department of Physics, Division of Materials Physics, University of Helsinki, P.O. Box 64, FI-00014 Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The developments in printing technologies allow fabrication of micron-size nano-layered delivery systems to personal specifications. In this study we fabricated layered polymer structures for drug-delivery into a microfluidic channel and aimed to interferometrically assure their topography and adherence to each other. We present a scanning white light interferometer (SWLI) method for quantitative assurance of the topography of the embedded structure. We determined rapidly in non-destructive manner the thickness and roughness of the structures and whether the printed layers containing polymers or/and active pharmaceutical ingredients (API) adhere to each other. This is crucial in order to have predetermined drug release profiles. We also demonstrate non-invasive measurement of a polymer structure in a microfluidic channel. It shown that traceable interferometric 3D microscopy is a viable technique for detailed structural quality assurance of layered drug-delivery systems. The approach can have impact and find use in a much broader setting within and outside life sciences.

Indexed as

Drug Delivery SystemsImaging, Three-DimensionalInterferometryMicrofluidic Analytical TechniquesMicroscopy, InterferenceNanostructuresPharmaceutical PreparationsPolymersPrecision MedicinePrintingSurface PropertiesPharmaceutical PreparationsPolymers

Identifiers

PMID24503863
PMCPMC3916789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.